On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Lofarma S.p.a.'s own share of each project, not the project's full budget.
- Horizon 2020€129k · 1 project
Projects
1 EU-funded project, newest first. Each links to the official record.
- TOLLerantPartner
Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach.
Horizon 2020 · 2015–2018 · Project on CORDIS ↗
€129ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Agencia Estatal Consejo Superior de Investigaciones CientificasSpain · 1 shared project
- Vib vzwBelgium · 1 shared project
- Universita Degli Studi di Napoli Federico IiItaly · 1 shared project
- Universita' Degli Studi di Milano-BicoccaItaly · 1 shared project
- Universitaet BielefeldGermany · 1 shared project
- Kemijski InstitutSlovenia · 1 shared project
- ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES- CIC biomaGUNESpain · 1 shared project
- Asociacion Centro de Investigacion Cooperativa en BiocienciasSpain · 1 shared project
- Diomune SLSpain · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- allergology
- asthma
- drug discovery
- immunotherapy
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
